United States - English - NLM (National Library of Medicine)

sandoz inc - candesartan cilexetil (unii: r85m2x0d68) (candesartan - unii:s8q36md2xx) - candesartan cilexetil 4 mg - candesartan cilexetil tablets are indicated for the treatment of hypertension in adults and children 1 to <17 years of age, to lower blood pressure. lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (j

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - candesartan cilexetil, quantity: 16 mg - tablet - excipient ingredients: magnesium stearate; maize starch; titanium dioxide; carrageenan; iron oxide red; povidone; croscarmellose sodium; lactose monohydrate - treatment of hypertension. . treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - candesartan cilexetil, quantity: 4 mg - tablet - excipient ingredients: lactose monohydrate; croscarmellose sodium; magnesium stearate; carrageenan; povidone; maize starch - treatment of hypertension. . treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - candesartan cilexetil, quantity: 32 mg - tablet - excipient ingredients: maize starch; magnesium stearate; titanium dioxide; povidone; lactose monohydrate; iron oxide red; carrageenan; croscarmellose sodium - treatment of hypertension. . treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - candesartan cilexetil, quantity: 8 mg - tablet - excipient ingredients: lactose monohydrate; carrageenan; maize starch; povidone; iron oxide red; croscarmellose sodium; titanium dioxide; magnesium stearate - treatment of hypertension. . treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction less than or equal to 40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - candesartan cilexetil -

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - candesartan cilexetil, quantity: 16 mg - tablet, uncoated - excipient ingredients: hyprolose; magnesium stearate; carmellose calcium; lactose monohydrate; macrogol 8000; maize starch; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - candesartan cilexetil, quantity: 4 mg - tablet, uncoated - excipient ingredients: macrogol 8000; maize starch; hyprolose; magnesium stearate; carmellose calcium; lactose monohydrate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - candesartan cilexetil, quantity: 4 mg - tablet, uncoated - excipient ingredients: carmellose calcium; magnesium stearate; maize starch; lactose monohydrate; hyprolose; macrogol 8000; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - candesartan cilexetil, quantity: 32 mg - tablet, uncoated - excipient ingredients: carmellose calcium; maize starch; lactose monohydrate; hyprolose; macrogol 8000; magnesium stearate; iron oxide red - treatment of hypertension.,treatment of patients with heart failure and impaired left ventricular systolic function (left ventricular ejection fraction <=40percent) as add-on therapy to ace inhibitors or when ace inhibitors are not tolerated.